These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36016208)

  • 21. Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines.
    Manriquez Roa T; Holzer F; Luna F; Biller-Andorno N
    Int J Public Health; 2021; 66():1604236. PubMed ID: 35035347
    [No Abstract]   [Full Text] [Related]  

  • 22. Global macroeconomic burden of epilepsy and the role for neurosurgery: a modelling study based upon the 2016 Global Burden of Disease data.
    O'Donohoe TJ; Choudhury A; Callander E
    Eur J Neurol; 2020 Feb; 27(2):360-368. PubMed ID: 31549472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Economic Consequences Of Mortality Amenable To High-Quality Health Care In Low- And Middle-Income Countries.
    Alkire BC; Peters AW; Shrime MG; Meara JG
    Health Aff (Millwood); 2018 Jun; 37(6):988-996. PubMed ID: 29863936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rural prioritization may increase the impact of COVID-19 vaccines in a representative COVAX AMC country setting due to ongoing internal migration: A modeling study.
    Selvaraj P; Wagner BG; Chao DL; Jackson ML; Breugelmans JG; Jackson N; Chang ST
    PLOS Glob Public Health; 2022; 2(1):e0000053. PubMed ID: 36962090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An economic case study of the control of dog-mediated rabies by an animal welfare organisation in Jaipur, India.
    Larkins AJ; Reece JF; Shaw APM; Thrusfield MV
    Prev Vet Med; 2020 Oct; 183():105120. PubMed ID: 32890917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa.
    Hassan MA; Aliyu S
    Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic Burden of Mental Illnesses in Pakistan.
    Malik MA; Khan MM
    J Ment Health Policy Econ; 2016 Sep; 19(3):155-66. PubMed ID: 27572143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macroeconomic costs of the unmet burden of surgical disease in Sierra Leone: a retrospective economic analysis.
    Grimes CE; Quaife M; Kamara TB; Lavy CBD; Leather AJM; Bolkan HA
    BMJ Open; 2018 Mar; 8(3):e017824. PubMed ID: 29540407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017
    Liu C; Shi J; Wang H; Yan X; Wang L; Ren J; Parascandola M; Chen W; Dai M
    Chin J Cancer Res; 2021 Feb; 33(1):79-92. PubMed ID: 33707931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
    Pilkington V; Keestra SM; Hill A
    Front Public Health; 2022; 10():821117. PubMed ID: 35321196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism design for a fair and equitable approach to global vaccine distribution: The case of COVID-19.
    Abedrabboh K; Al-Majid L; Al-Fagih Z; Al-Fagih L
    PLOS Glob Public Health; 2023; 3(12):e0001711. PubMed ID: 38153908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality by cause for eight regions of the world: Global Burden of Disease Study.
    Murray CJ; Lopez AD
    Lancet; 1997 May; 349(9061):1269-76. PubMed ID: 9142060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
    Sharun K; Dhama K
    Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.
    Rodin D; Burger EA; Atun R; Barton M; Gospodarowicz M; Grover S; Hanna TP; Jaffray DA; Knaul FM; Lievens Y; Zubizarreta E; Milosevic M
    Lancet Oncol; 2019 Jul; 20(7):915-923. PubMed ID: 31151906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance.
    Lee LA; Franzel L; Atwell J; Datta SD; Friberg IK; Goldie SJ; Reef SE; Schwalbe N; Simons E; Strebel PM; Sweet S; Suraratdecha C; Tam Y; Vynnycky E; Walker N; Walker DG; Hansen PM
    Vaccine; 2013 Apr; 31 Suppl 2():B61-72. PubMed ID: 23598494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.
    Kim SY; Sweet S; Chang J; Goldie SJ
    BMC Infect Dis; 2011 Jun; 11():174. PubMed ID: 21679420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysis.
    Obeng-Kusi M; Erstad B; Roe DJ; Abraham I
    J Med Econ; 2022; 25(1):894-902. PubMed ID: 35748085
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.